Approvals/TGA/KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial

Approved

STANDARD

KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial

Approval Id: b5ea3465f90e85e6
Product Name: KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial
Artg Id: 274498
Artg Name: KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial
Sponsor: Alexion Pharmaceuticals Australasia Pty Ltd
Company Detail Path: /organization/alexion-pharmaceuticals-australasia-pty-ltd
Artg Date: 2017-05-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/edd8afce784d0cac4a711860de4f2ab7.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1730cdf225d33505684de8913e86ff2d.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b5ea3465f90e85e6

Type

Standard